Vaxart Files Definitive Additional Materials Proxy Statement
Ticker: VXRT · Form: DEFA14A · Filed: May 28, 2025 · CIK: 72444
| Field | Detail |
|---|---|
| Company | Vaxart, Inc. (VXRT) |
| Form Type | DEFA14A |
| Filed Date | May 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, shareholder-meeting, corporate-governance
Related Tickers: VXRT
TL;DR
Vaxart dropped proxy materials - shareholders vote soon.
AI Summary
Vaxart, Inc. filed a Definitive Additional Materials proxy statement on May 28, 2025. This filing relates to the company's annual meeting and likely concerns proposals for shareholder voting, such as director elections or executive compensation, as is typical for a DEFA14A filing.
Why It Matters
This filing provides shareholders with crucial information and voting materials for the company's upcoming annual meeting, impacting corporate governance and strategic decisions.
Risk Assessment
Risk Level: medium — DEFA14A filings are routine but can signal upcoming shareholder votes on significant matters like mergers, executive pay, or board changes, which carry inherent risks.
Key Players & Entities
- Vaxart, Inc. (company) — Registrant
- 0001437749-25-018647 (filing_id) — Accession Number
- 20250528 (date) — Filing Date
FAQ
What type of filing is this DEFA14A for Vaxart, Inc.?
This is a Definitive Additional Materials filing, indicating it supplements previously filed proxy materials.
When was this filing made by Vaxart, Inc.?
The filing was made on May 28, 2025.
What is the Central Index Key (CIK) for Vaxart, Inc.?
The CIK for Vaxart, Inc. is 0000072444.
What is Vaxart, Inc.'s Standard Industrial Classification (SIC) code?
Vaxart, Inc.'s SIC code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What was Vaxart, Inc. formerly known as?
Vaxart, Inc. was formerly known as Aviragen Therapeutics, Inc. (name change 20160413), Biota Pharmaceuticals, Inc. (name change 20121113), and NABI BIOPHARMACEUTICALS (name change 20100719).
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 28, 2025 regarding Vaxart, Inc. (VXRT).